Law Office of Brodsky & Smith, LLC Announces Investigation of Orthovita, Inc.
20 Mayo 2011 - 5:56PM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Orthovita, Inc. (“Orthovita” or the “Company”) (Nasdaq - VITA)
relating to the proposed acquisition by Stryker Corp.
(“Stryker”).
Under the terms of the transaction, Orthovita shareholders would
receive $3.85 in cash for each share of common stock they own. The
investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of
Orthovita by not acting in Orthovita shareholders' best interests
in connection with the sale process to Stryker. The transaction may
undervalue Orthovita as an analyst has set a price target of $4.00
per share on Orthovita stock.
If you own shares of Orthovita stock and wish to discuss the
legal ramifications of the proposed transaction, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or
Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza,
Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/291-vita-orthovita-inc.html, or by calling
toll free 877-LEGAL-90.
Orthovita, Inc. (MM) (NASDAQ:VITA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Orthovita, Inc. (MM) (NASDAQ:VITA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Orthovita, Inc. (MM) (NASDAQ): 0 recent articles
Más de Brodsky & Smith, LLC Artículos de Noticias